Bridgefront Capital, LLC Royalty Pharma PLC Transaction History
Bridgefront Capital, LLC
- $278 Million
- Q4 2024
A detailed history of Bridgefront Capital, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Bridgefront Capital, LLC holds 12,205 shares of RPRX stock, worth $400,934. This represents 0.11% of its overall portfolio holdings.
Number of Shares
12,205Holding current value
$400,934% of portfolio
0.11%Shares
3 transactions
Others Institutions Holding RPRX
# of Institutions
428Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.3 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.23 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$756 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$557 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$464 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...